期刊文献+

Aberrant DNA methylation profile in cholangiocarcinoma 被引量:3

Aberrant DNA methylation profile in cholangiocarcinoma
下载PDF
导出
摘要 Cholangiocarcinoma(CCA)is a notoriously lethal epith-elial cancer originating from the biliary system.As radical resection offers a poor success rate and limited effective adjuvant modalities exist in its advanced stage,the disease leads to a fairly poor prognosis.As the incidence of CCA is increasing,although the mortality rate remains stable,and few other definite etiologies have yet to be established,renewing our knowledge of its fundamental carcinogenesis is advisable.The latest advances in molecular carcinogenesis have highlighted the roles of epigenetic perturbations and cancer-related inflammation in CCA.This review focuses on the reciprocal effects between aberrant DNA methylation and inflammatory microenvironment in CCA. Cholangiocarcinoma (CCA) is a notoriously lethal epithelial cancer originating from the biliary system. As radical resection offers a poor success rate and limited effective adjuvant modalities exist in its advanced stage, the disease leads to a fairly poor prognosis. As the incidence of CCA is increasing, although the mortality rate remains stable, and few other definite etiologies have yet to be established, renewing our knowledge of its fundamental carcinogenesis is advisable. The latest advances in molecular carcinogenesis have highlighted the roles of epigenetic perturbations and cancer-related inflammation in CCA. This review focuses on the reciprocal effects between aberrant DNA methylation and inflammatory microenvironment in CCA.
出处 《World Journal of Gastrointestinal Pathophysiology》 CAS 2010年第2期23-29,共7页 世界胃肠病理生理学杂志(英文版)(电子版)
基金 Supported by an NIH K01 Grant Award(DK078532) to Dr.DeMorrow
关键词 CHOLANGIOCARCINOMA EPIGENOME DNA METHYLATION Cancer-related inflammation MICROENVIRONMENT Cholangiocarcinoma Epigenome DNA methylation Cancer-related inflammation Microenvironment
  • 相关文献

参考文献78

  • 1Monique Stutes,Steven Tran,Sharon DeMorrow.Genetic and epigenetic changes associated with cholangiocarcinoma:From DNA methylation to microRNAs[J].World Journal of Gastroenterology,2007,13(48):6465-6469. 被引量:11
  • 2Andrea T. Borchers,Shinji Shimoda,Christopher Bowlus,Carl L. Keen,M. Eric Gershwin.Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis[J]. Seminars in Immunopathology . 2009 (3)
  • 3Ren Xu,Aaron Boudreau,Mina J. Bissell.Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices[J]. Cancer and Metastasis Reviews . 2009 (1-2)
  • 4Iris Tischoff,Christian Wittekind,Andrea Tannapfel.Role of epigenetic alterations in cholangiocarcinoma[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 2006 (4)
  • 5Kobayashi S,Werneburg NW,Bronk SF,Kaufmann SH,Gores GJ.Interleukin-6contributes to Mcl-1up-regulation and TRAIL resistance via an Akt-signaling pathway in cho-langiocarcinoma cells. Gastroenterology . 2005
  • 6Park J,Tadlock L,Gores GJ,Patel T.Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation atte-nuates growth of a cholangiocarcinoma cell line. Hepatology . 1999
  • 7Ye Y,Zhou L,Xie X,Jiang G,Xie H,Zheng S.Interaction of B7-H1on intrahepatic cholangiocarcinoma cells with PD-1on tumor-infiltrating T cells as a mechanism of immune evasion. Journal of Surgical Oncology . 2009
  • 8Kobayashi N,Hiraoka N,Yamagami W,Ojima H,Kanai Y,Kosuge T,Nakajima A,Hirohashi S.FOXP3+regu-latory T cells affect the development and progression of hepatocarcinogenesis. Clinical Cancer Research . 2007
  • 9Choi YE,Yu HN,Yoon CH,Bae YS.Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter. European Journal of Immunology . 2009
  • 10Hezel AF,Zhu AX.Systemic therapy for biliary tract can-cers. The Oncologist . 2008

二级参考文献3

共引文献38

同被引文献3

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部